Executive Summary — Q1 2026
Alvio Labs delivered a net loss of €4,226.52 for Q1 2026, representing a significant improvement of €6,740.33 (61% reduction) compared to Q1 2025's loss of €10,966.85. This improvement was driven primarily by efficient cost management, with Cost of Goods Sold declining by 71% YoY despite increased operational tooling investments.
However, the business remains in a critical cash position. With only €116 in cash reserves and a monthly burn rate of €398, runway has effectively been depleted. Director funding continues to sustain operations, with combined director contributions totaling €36,247.62 across current and loan accounts. Revenue generation remains at zero, requiring immediate strategic action to secure operating capital.
Cash Position
€116.00
Q1 Net Loss
€4,226.52
Monthly Burn Rate
~€398
Total Equity
-€35,940
Financial Position Overview
Total Assets
€116.00
-78% vs Q1 2025 (€532.14)
Total Liabilities
€36,056.06
+141% vs Q1 2025 (€14,948.99)
Net Assets
-€35,940.06
Negative equity position
P&L Executive Summary
Q1 2026 delivered a net loss of -€4,226.52, representing a significant improvement compared to Q1 2025's loss of €10,966.85. However, the company remains pre-revenue with costs driven primarily by software subscriptions, consulting fees, and R&D investments. The 94% increase in operating expenses reflects expanded tooling and professional services as the business scales operations.
Critical insight: While losses are narrowing, the current cash position of €116 provides less than 3 days of runway at the current monthly burn rate. Immediate capital injection or revenue generation is required to sustain operations beyond Q2 2026.
Net Profit Q1 2026
-€4,226.52
Gross Profit
-€3,032.07
Operating Expenses
€1,194.45
Monthly Burn Rate
~€398
Operating Expense Breakdown Q1 2026
Analyst Note
Consulting & Accounting is now the largest expense category at €613.00 (51% of OpEx), reflecting increased reliance on external professional services. Bank fees have decreased 80% YoY, suggesting better account management.
P&L Line Items Comparison
| Account | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Cost of Goods Sold | €3,032.07 | €10,350.00 | -€7,317.93 |
| Consulting & Accounting | €613.00 | €405.90 | +€207.10 |
| Office Software Expenses | €271.65 | €2.68 | +€268.97 |
| Research & Development | €191.98 | €198.27 | -€6.29 |
| Office Expenses | €53.47 | €0.00 | +€53.47 |
| Subscriptions | €42.36 | €0.00 | +€42.36 |
| Travel - National | €20.00 | €0.00 | +€20.00 |
| Bank Fees | €1.99 | €10.00 | -€8.01 |
Balance Sheet Summary
As of 31 March 2026, Alvio Labs holds €116.00 in total assets, down from €532.14 in Q1 2025. The dramatic reduction reflects cash depletion to fund operations. Total liabilities have increased 141% to €36,056.06, primarily driven by director funding in the form of current account (€23,697.62) and loan (€12,550.00) balances.
The negative equity position of -€35,940.06 represents accumulated losses. Current Year Earnings stand at -€4,226.52 for Q1 2026, while Retained Earnings from prior periods total -€31,713.54.
Total Assets
€116.00
Total Liabilities
€36,056.06
Net Assets
-€35,940.06
Balance Sheet Composition
Liability Breakdown
Cash Flow Critical Alert
Cash position has declined from €532.14 (Q1 2025) to €116.00 (Q1 2026), representing a 78% reduction. This €416.14 cash outflow over the trailing 12 months averages approximately €35 per month in net cash burn, though recent months show accelerating depletion.
Immediate action required: The current cash balance of €116 will be exhausted within 1-2 weeks at the current monthly burn rate of €398. Director funding has sustained operations, but reliance on shareholder financing is not sustainable without a clear path to profitability or external investment.
Cash Inflow (12mo)
€890.00
From director loans & revenue
Cash Outflow (12mo)
-€1,306.17
Operating expenses & bank fees
Recent Bank Transactions
| Date | Description | Type | Amount |
|---|---|---|---|
| 2025-06-25 | Replit Inc | SPEND | -€19.79 |
| 2025-06-14 | Bank Fee | SPEND | -€10.00 |
| 2025-06-10 | Replit Inc | SPEND | -€8.06 |
| 2025-06-01 | Cursor | SPEND | -€17.68 |
| 2025-06-01 | Bank Fee | SPEND | -€0.18 |
| 2025-05-28 | Revenue Commission | RECEIVE | +€40.00 |
| 2025-05-14 | Bank Fee | SPEND | -€10.00 |
| 2025-05-12 | Venturekit.ai | SPEND | -€85.42 |
| 2025-05-11 | Director Loan (Shubham Jain) | RECEIVE | +€50.00 |
| 2025-05-09 | Director Loan (Shubham Jain) | RECEIVE | +€250.00 |